Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma

Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here we describe a patient with dyspnea and general weakness because of comp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Lee, Won-Seop, Kim, Dae-Hyeok, Shin, Sung-Hee, Woo, Seoung-Il, Kwan, Jun, Park, Keum-Soo, Park, Sang-Don, Yi, Hyeon-Gyu, Jeon, Sang-Hoon
Format: Artigo
Jezik:Inglês
Izdano: Yonsei University College of Medicine 2011
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3017698/
https://ncbi.nlm.nih.gov/pubmed/21155055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2011.52.1.196
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki